annb0t
Top 20
ResMed Inc.'s RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2023 were $1.51, unchanged year over year. The metric also came in line with the Zacks Consensus Estimate.
The adjustments include certain non-recurring expenses/benefits like amortization of acquired intangibles and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.43, up 2.9% from the year-ago quarterâs EPS.
Revenues
Fiscal first-quarter revenues on a reported basis inc...
>>> Read more: ResMed (RMD) Q1 Earnings In Line, Operating Margin Falls
The adjustments include certain non-recurring expenses/benefits like amortization of acquired intangibles and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.43, up 2.9% from the year-ago quarterâs EPS.
Revenues
Fiscal first-quarter revenues on a reported basis inc...
>>> Read more: ResMed (RMD) Q1 Earnings In Line, Operating Margin Falls
